FDA Inspection
Piedmont Columbus Regional MidtownPiedmont Columbus Regional Midtown – FDA Inspection, Jun 4, 2019
Record Details
This FDA Inspection record concerns Piedmont Columbus Regional Midtown, with an inspection on June 4, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 557ed37b-a0d3-4286-929d-a43a1a26ccb5
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1096339
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Piedmont Columbus Regional Midtown
4| Date | Classification | Office | Project area |
|---|---|---|---|
| July 16, 2026 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 11, 2024 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 18, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 25, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Piedmont Columbus Regional Midtown
- FDA Inspection 1328606 - 2026-07-16
- FDA Inspection 1243509 - 2024-07-11
- FDA Inspection 970689 - 2016-05-18
- FDA Inspection 868637 - 2014-02-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.